Mental Health and Suicidality in Glioblastoma Patients in Germany
Recruiting
Observational Study
Glioblastoma (GBM)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 176 (estimated)
- Sponsor
- University Hospital, Essen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of glioblastoma, IDH wild-type (CNS WHO classification of 2021)
* Age ≥ 18 years
Exclusion Criteria:
* Participants with clinically significant aphasia or language barrier as assessed by the investigator
* History of other malignant tumors
* Known tumor predisposit…
Contacts